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The association between tobacco smoke and acute myeloid leukemia (AML) is well established in adults but not
in children. Individual-level data on parental cigarette smoking were obtained from 12 case-control studies from the
Childhood Leukemia International Consortium (CLIC, 1974–2012), including 1,330 AML cases diagnosed at age
<15 years and 13,169 controls. We conducted pooled analyses of CLIC studies, as well as meta-analyses of CLIC
and non-CLIC studies. Overall, maternal smoking before, during, or after pregnancy was not associated with child-
hood AML; there was a suggestion, however, that smoking during pregnancy was associated with an increased risk
in Hispanics (odds ratio = 2.08, 95% confidence interval (CI): 1.20, 3.61) but not in other ethnic groups. By contrast,
the odds ratios for paternal lifetime smoking were 1.34 (95% CI: 1.11, 1.62) and 1.18 (95% CI: 0.92, 1.51) in pooled
and meta-analyses, respectively. Overall, increased risks from 1.2- to 1.3-fold were observed for pre- and postnatal
smoking (P < 0.05), with higher risks reported for heavy smokers. Associations with paternal smoking varied by
histological type. Our analyses suggest an association between paternal smoking and childhood AML. The asso-
ciation with maternal smoking appears limited to Hispanic children, raising questions about ethnic differences in
tobacco-related exposures and biological mechanisms, as well as study-specific biases.
acute myeloid leukemia; childhood cancer; international collaboration; parental smoking
Abbreviations: AML, acute myeloid leukemia; CI, confidence interval; CLIC, Childhood Leukemia International Consortium;
FAB, French-American-British; OR, odds ratio.
Acute lymphoblastic leukemia is the most common cancer
in children 0–14 years of age, whereas acute myeloid leuke-
mia (AML) represents 2%–5% of childhood cancers (1, 2).
The incidence of childhood AML varies geographically,
with higher rates in children from Asian and Hispanic de-
scents (3). It is well established that exposure to tobacco
smoke is a risk factor for AML in adults (4). Numerous stud-
ies demonstrate that myeloid cells can be damaged by
tobacco smoke carcinogens, including benzene, formalde-
hyde, 1,3-butadiene, polycyclic aromatic hydrocarbons, and
polonium (4–8). Although it has been hypothesized that to-
bacco smoke may affect both somatic cells and germ cells
during critical periods of a child’s development (7), the po-
tential contribution of tobacco smoke to the development of
AML in children has not been as well studied as it has in
adults. Most studies of childhood AML report no associa-
tions with maternal smoking during pregnancy (9–22), al-
though modest increased risks were observed in 2 small
case-control studies (11, 12) and 2 registry-based Swedish
cohort studies (23, 24). Studies on paternal smoking and
childhood AML have yielded mixed results, some reporting
elevated risks for lifetime smoking (18, 25), some for pre-
conception smoking (17), and others no associations (9, 12,
26, 27).
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Individual studies of childhood AML to date are based on
small numbers because of the rarity of the disease and have
included mostly Caucasian children. To overcome these
shortcomings, we pooled data on maternal and paternal to-
bacco smoking from 12 case-control studies participating in
the Childhood Leukemia International Consortium (CLIC)
(28) and examined the associations of pre- and postnatal
exposures to tobacco smoke with risk of childhood AML.
Additionally, we conducted meta-analyses of CLIC and non-
CLIC studies.
METHODS
Study population
Twelve case-control studies of childhood leukemia (age
<15 years) conducted in 10 countries from 1974 to 2012
and participating in CLIC (28) contributed data to the pooled
analyses (Web Table 1 available at http://aje.oxfordjournals.
org/). This included 9 studies with published data: Brazil
(limited to infants <24 months of age) (29), the United
Kingdom (United Kingdom Childhood Cancer Study) (19),
France (Adele; Epidemiologic Study on Childhood Cancer
and Leukemia) (20, 21), Germany (German Childhood Cancer
Registry) (22), Greece (Nationwide Registration for Child-
hood Hematological Malignancies) (30), Italy (Study on
the Etiology of Childhood Lymphohematopoietic Malignan-
cies) (25), and the United States (Northern California Child-
hood Leukemia Study (18) and linked registry data from
Washington State (31)), as well as 3 studies with unpublished
data at the time of this report from Costa Rica, Mexico (Mex-
ican Interinstitutional Group for the Identiﬁcation of the
Causes of Childhood Leukemia), and New Zealand (New
Zealand Childhood Cancer Study). Study characteristics
are presented in Web Table 2 (28). Data for 1,330 newly di-
agnosed de novo AML cases and 13,169 controls were avail-
able for the pooled analyses.
Data collection and standardization
CLIC studies provided original data on self-reported ma-
ternal and paternal tobacco (cigarette) smoking for “ever/
never smoking,” smoking during speciﬁc time windows
(preconception, during pregnancy as a whole and/or by
Table 1. Clinical and Sociodemographic Characteristics of Acute
Myeloid Leukemia Cases and Controls, Childhood Leukemia
International Consortium, 1974–2012a
Variable
Controls
(n = 13,169)
Cases
(n = 1,330)
No. % No. %
FAB subtype (cases only)
M0 46 3
M1 94 7
M2 256 19
M3 140 11
M4 162 12
M5 158 12
M6 28 3
M7 101 2
Unspecified/missing 346 26
Child’s age, yearsb
<1 1,174 9 176 13
1–4 5,752 44 474 36
5–9 3,566 27 330 25
10–14 2,677 20 350 26
Child’s sex
Male 7,299 55 706 53
Female 5,870 45 624 47
Parent’s highest educational levelc
None/primary 2,611 20 284 22
Secondary 4,710 37 458 35
Tertiary 5,386 42 533 41
Missing 154 1 21 2
Table continues
Table 1. Continued
Variable
Controls
(n = 13,169)
Cases
(n = 1,330)
No. % No. %
Child’s ethnicityd
Non-Hispanic white 10,363 79 860 65
Hispanic 1,711 13 372 28
Non-Hispanic other 1,018 8 90 7
Missing 77 1 8 1
Mother’s age at child’s birth, years
<25 3,688 28 414 31
25–29 4,555 35 448 34
30–34 3,319 25 305 23
≥35 1,575 12 158 12
Missing 32 0 5 0
Father’s age at child’s birth, years
<25 1,785 14 247 19
25–29 3,762 29 360 27
30–34 3,868 29 350 26
≥35 3,297 25 331 25
Missing 457 4 42 3
Abbreviations and designations: FAB, French-American-British; M0,
acute myeloblastic leukemia, minimally differentiated; M1, acute
myeloblastic leukemia, without maturation; M2, acute myeloblastic
leukemia, with graulocytic maturation; M3, acute promyelocytic leukemia;
M4, acute myelomonocytic leukemia; M5, acute monoblastic/monocytic
leukemia; M6, acute erythroid leukemia; M7, acutemegaloblastic leukemia.
a Percentages may not sum to 100 because of rounding.
b Child’s age at diagnosis for cases and recruitment for controls.
c Does not include missing values for Washington State.
d Studies that did not provide ethnicity data were automatically
assigned themost common ethnicity based on population-based data.
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trimester, and after birth), and duration (Web Table 1). Data
on maternal tobacco smoking during pregnancy were the
most complete (12 studies), compared with other smoking-
related data (6–9 studies) (Web Table 1). Information on pa-
rental smoking was collected from interviews with mothers
and/or fathers (Northern California Childhood Leukemia
Study, German Childhood Cancer Registry, Nationwide
Registration for Childhood Hematological Malignancies,
United Kingdom Childhood Cancer Study, Costa Rica,
Study on the Etiology of Childhood Lymphohematopoietic
Malignancies, the Mexican Interinstitutional Group for the
Identiﬁcation of the Causes of Childhood Leukemia), moth-
ers only (Adele; Epidemiologic Study on Childhood Cancer
and Leukemia, New Zealand Childhood Cancer Registry,
Brazil), or via maternal self-report or medical/prenatal record
review (United States-Washington State). We also obtained
Table 2. Pooled Risk of Childhood Acute Myeloid Leukemia Associated With Maternal Smoking Across Time
Periods, Childhood Leukemia International Consortium, 1974–2012
Window of Exposure
Total
Controls,
no.
Total
Cases,
no.
Exposed, %
ORa 95% CI
Controls Cases
Ever-smoking 5,929 563 42 42 1.01 0.84, 1.22
Smoking during prenatal periodb 12,631 1,266 29 26 0.93 0.81, 1.07
Smoking during preconception periodb 10,137 1,012 31 27 0.89 0.76, 1.04
Smoking during pregnancyb 12,621 1,266 19 15 0.95 0.81, 1.13
Smoking after birth 10,229 1,028 28 26 0.96 0.82, 1.12
Abbreviations: CI, confidence interval; OR, odds ratio.
a Odds ratios were adjusted for age, sex, ethnicity, highest parental education, and study center.
b Odds ratios were computed by using imputed values of education.
Table 3. Risk of Acute Myeloid Leukemia Associated With Maternal Smoking During Pregnancy, by Selected
Characteristics, Childhood Leukemia International Consortium, 1974–2012
Variable
Total
Controls,
no.
Total
Cases,
no.
Exposed, %
ORa,b 95% CI
P Value for
InteractioncControls Cases
Child’s ethnicity <0.01
Non-Hispanic white 7,732 644 23 19 0.82 0.66, 1.01
Hispanic 1,130 332 5 7 2.08 1.20, 3.61
Non-Hispanic other 1,013 89 13 16 1.08 0.56, 2.07
Highest parental education 0.98
None/primary 2,605 284 27 23 0.85 0.58, 1.24
Secondary 4,851 464 23 17 0.93 0.69, 1.24
Tertiary 5,493 553 12 10 0.99 0.71, 1.39
Child’s birth weight, g 0.53
Low birth weight (<2,500) 1,039 108 25 16 0.58 0.29, 1.17
Normal birth weight (2,500–4,000) 10,831 1,091 19 15 0.95 0.77, 1.17
High birth weight (>4,000) 1,219 121 12 16 1.20 0.65, 2.19
Child’s age, years 0.93
Age <1 1,169 175 17 17 1.08 0.66, 1.78
Age 1–4 5,725 472 20 15 0.97 0.72, 1.32
Age 5–9 3,542 327 19 17 0.83 0.55, 1.25
Age 10–14 2,653 346 18 14 0.83 0.57, 1.20
Abbreviations: CI, confidence interval; OR, odds ratio.
a Odds ratios were adjusted for age, sex, ethnicity, highest parental education, and study center, except when it was
the variable of interest.
b Odds ratios were computed by using imputed values of education.
c P value for interaction derived from the Woolf test.
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data on child’s race/ethnicity, sex, age (at diagnosis for cases and
corresponding age for matched controls or age at enrollment/
interview), birth weight, parental ages at the time of the
child’s birth, maternal consumption of alcohol during preg-
nancy, home exposure to paints and solvents, and parental
educational level (highest level achieved by mother or father
at the time of the child’s birth). The Washington State study
provided imputed values for missing data on parental educa-
tion, using methods previously described (32). All studies,
except those in Brazil, Costa Rica, and Germany (German
Childhood Cancer Registry), provided data on AML subtype
according to the French-American-British (FAB) classiﬁca-
tion (Table 1). Four studies (United Kingdom Childhood
Cancer Study, Adele, Epidemiologic Study on Childhood
Table 4. Pooled Risk of Childhood Acute Myeloid Leukemia Associated With Paternal Smoking Across Time
Periods, Childhood Leukemia International Consortium, 1974–2012
Window of Exposure
Total
Controls,
no.
Total
Cases,
no.
Exposed, %
ORa 95% CI
Controls Cases
Ever-smoking 5,538 528 53 60 1.34 1.11, 1.62
Smoking during prenatal period 11,080 1,094 45 51 1.24 1.08, 1.42
Smoking during preconception period 7,699 860 46 50 1.18 1.01, 1.38
Smoking during pregnancy 7,337 810 44 48 1.24 1.06, 1.46
Smoking after birth 11,199 1,035 42 50 1.27 1.11, 1.45
Abbreviations: CI, confidence interval; OR, odds ratio.
a Odds ratios were adjusted for age, sex, ethnicity, highest parental education, and study center.
Fixed effects (I2 = 0.0%, P = 0.468)
Severson, 1993 (13)
Fixed effects (I2 = 0.0%, P = 0.584)
Non−CLIC
Metayer, 2013 (18)
Brondum, 1999 (9)
CLIC
Mattioli, 2014 (25)
First Author, Year (Reference No.)
Fixed effects (I2 = 43.4%, P = 0.171)
Random effects
Magnani, 1990 (26)
C. Wesseling, unpublished data, 1995−2000
Pang, 2003 (19)
J. D. Dockerty, unpublished data, 1990−1995
Random effects
Menegaux, 2005 (20)
Random effects
1.02 (0.88, 1.18)
1.32 (0.85, 2.05)
0.97 (0.79, 1.20)
1.00 (0.67, 1.48)
0.95 (0.74, 1.22)
1.19 (0.67, 2.13)
Odds Ratio (95% CI)
1.07 (0.86, 1.32)
1.02 (0.88, 1.18)
2.00 (0.80, 5.00)
1.40 (0.58, 3.36)
0.97 (0.70, 1.36)
0.80 (0.21, 2.98)
1.16 (0.82, 1.64)
0.54 (0.26, 1.12)
0.97 (0.79, 1.20)
0.20 1.00 5.00
Figure 1. Study-specific odds ratios and fixed- and random-effects meta-analysis odds ratios for maternal ever-smoking and risk of acute myeloid
leukemia in selectedChildhood Leukemia International Consortium (CLIC) and non-CLIC studies between 1990–2014. Odds ratios for CLIC studies
were generated by using original data. TheP value for heterogeneity between groups is 0.552. The vertical solid line represents the reference for “no
association,” and the dashed line represents the risk estimate from the fixed-effect meta-analysis. CI, confidence interval.
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Cancer and Leukemia, and Northern California Childhood Leu-
kemia Study) provided information on the presence of the
mixed lineage leukemia gene (MLL) translocation (11q23) de-
tected by ﬂuorescence in situ hybridization.
Data were reviewed by CLIC principal investigators and
harmonized for pooling. Variables with heterogeneous deﬁ-
nitions across studies were categorized for periods of smok-
ing (Web Table 3), highest levels of parental education (none/
primary, secondary, and tertiary), and ethnicity (Hispanic,
non-Hispanic white/Caucasian/European, later referred to
as non-Hispanicwhite, and non-Hispanic other) (WebTable 4).
Studies from Germany, Italy, and Costa Rica did not collect
data on subject-speciﬁc ethnicity; on the basis of population-
based data, all subjects in Germany and Italy were considered
non-Hispanic white, and all subjects in Costa Rica were con-
sidered Hispanic.
Statistical analyses
Study-speciﬁc and pooled odds ratios and 95% conﬁdence
intervals were estimated by using unconditional logistic re-
gression models. Parents’ and child’s age and birth weight
were treated as continuous variables. The amount of smoking
was analyzed by using data as reported and categorical vari-
ables based on the observed frequency distribution among
controls (nonsmokers, moderate smokers (1–15 cigarettes
per day), and heavy smokers (≥16 cigarettes per day)). Mod-
els were adjusted for child’s age, sex, and ethnicity, because
these variables were used as matching factors in the individ-
ual studies. We also adjusted for parental educational level (a
surrogate for socioeconomic status found to be a confounder
and/or indicator of selection bias in individual studies) and
study center. Other potential confounders (parental age at de-
livery, maternal alcohol intake, birth weight, and home expo-
sure to paints and solvents) were not retained in the ﬁnal
additive models because their inclusion did not alter the
odds ratio by more than 10%, and none were effect modiﬁers
in the multiplicative models. In stratiﬁed analyses, P < 0.20
was used as a threshold for the statistical signiﬁcance of het-
erogeneity between strata, using likelihood ratio techniques
or Woolf’s test. We conducted sensitivity analyses to assess
the robustness of our results by systematically excluding 2
studies at a time (Web Figure 1).
To further assess study heterogeneity, we conducted meta-
analyses for CLIC studies and non-CLIC studies. For CLIC
studies, we computed the study-speciﬁc odds ratios using the
original study design and corresponding unconditional or
conditional regression models adjusted for study-speciﬁc
confounders. A systematic search in PubMed, Embase, and
Web of Science identiﬁed 24 studies of childhood AML and
parental smoking, including 13CLIC and 11 non-CLIC studies
(details in Web Figure 2, based on Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) guide-
lines) (33). The following search terms were used: “(pediatric
OR childhood) AND leukemia AND (tobacco OR smok*)
AND (parent* OR maternal OR paternal)” in PubMed,
Table 5. Risk of Acute Myeloid Leukemia Associated With Paternal Ever-Smoking, by Selected Characteristics,
Childhood Leukemia International Consortium, 1974–2012
Variable
Total
Controls,
no.
Total
Cases,
no.
Exposed, %
ORa 95% CI
P Value for
InteractionbControls Cases
Child’s ethnicity 0.08
Non-Hispanic white 3,951 307 54 58 1.10 0.87, 1.41
Hispanic 506 61 42 52 1.45 0.84, 2.50
Non-Hispanic other 475 47 47 64 1.81 0.94, 3.49
Highest parental education 0.26
None/primary 815 116 66 78 1.71 0.87, 3.39
Secondary 2,242 215 58 60 1.09 0.79, 1.50
Tertiary 2,487 197 44 50 1.25 0.92, 1.70
Child’s birth weight, g 0.96
Low birth weight (<2,500) 479 41 56 71 1.39 0.58, 3.32
Normal birth weight (2,500–4,000) 4,482 426 53 61 1.21 0.96, 1.53
High birth weight (>4,000) 599 64 49 55 1.32 0.76, 2.29
Child’s age, years 0.74
Age <1 247 56 52 50 1.04 0.55, 1.96
Age 1–4 2,574 187 49 58 1.36 0.96, 1.94
Age 5–9 1,583 141 55 66 1.35 0.86, 2.12
Age 10–14 1,156 147 58 63 1.11 0.74, 1.65
Abbreviations: CI, confidence interval; OR, odds ratio.
a Odds ratios were adjusted for age, sex, ethnicity, highest parental education level, and study center, except when
it was the variable of interest.
b P value for interaction was derived from the −2 log likelihood estimate from multivariate analyses.
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Embase and Web of Science; reference lists of a published re-
view paper (16) and a meta-analysis (30) were also screened.
The search resulted in 268 papers, and 23 passed the 6 exclu-
sion criteria (Web Figure 2). For those, the following informa-
tion was extracted: author’s name, publication year, country
where the study was conducted, case-control design (individ-
ually or frequency matched), sample size (cases and controls),
and any measure of association for parental smoking. The
search and data abstraction were conducted by 1 investigator,
and quality control was performed by an independent investi-
gator. Funnel plots were generated and showed no indication
of publication biases (data not shown). Meta odds ratios for
yes/no smoking at various times were estimated for CLIC
and non-CLIC studies and all studies combined using random
and ﬁxed effect models; the I2 statistics were used as a measure
of heterogeneity (34).
RESULTS
Sociodemographic characteristics were similar for cases
and controls with the exception of ethnicity, likely because
of the inclusion of a large number of controls from Europe
(Table 1). Overall, paternal tobacco smoking was least prev-
alent in the United States, and fathers smoked more than
mothers in all countries (Tables 2–4). The ϕ correlation coef-
ﬁcients between maternal and paternal smoking ranged from
0.26 to 0.32 for various periods (data not shown). The ϕ cor-
relation coefﬁcients between periods were greater than 0.68 for
mothers and 0.91 for fathers. Among smokers, 91% of fathers
and 49% of mothers smoked from preconception to after birth,
and 37% of mothers stopped smoking during pregnancy.
Overall, maternal smoking during any time period was not
associated with increased risks of childhood AML in pooled
analyses (Table 2) or in meta-analyses of CLIC and non
CLIC studies (Figure 1 and Web Figures 3–5). However, in
pooled analyses restricted to Hispanic children, maternal
smoking during pregnancy was associated with a 2-fold in-
creased risk of AML (95% CI: 1.20, 3.61), whereas no in-
creased risks were observed for other ethnic groups (P for
interaction < 0.01) (Table 3). Data on Hispanics were from
studies in Mexico (257 cases and 520 controls; odds ratio
(OR) = 1.68, 95% CI: 0.77, 3.66); Costa Rica (34 cases and
558 controls; OR = 2.42, 95% CI: 0.43, 13.62); California
(64 cases and 517 controls; OR = 2.02, 95% CI: 0.84, 4.89);
Fixed effects (I2 = 45.8%, P = 0.055)
Random effects
J. D. Dockerty, unpublished data, 1990−1995
Menegaux, 2005 (20)
Fixed effects (I2 = 0.0%, P = 0.969)
Non−CLIC
Wen, 2000 (27)
Magnani, 1990 (26)
Random effects
MacArthur, 2008 (12)
Metayer, 2013 (18)
Pang, 2003 (19)
Fixed effects (I2 = 56.1%, P = 0.044)
C. Wesseling, unpublished data, 1995−2000
Mattioli, 2014 (25)
First Author, Year (Reference No.)
Random effects
CLIC
Brondum, 1999 (9)
1.10 (0.94, 1.29)
0.91 (0.72, 1.15)
4.50 (0.97, 20.83)
0.70 (0.32, 1.54)
0.91 (0.72, 1.15)
1.00 (0.57, 1.77)
0.90 (0.30, 2.70)
1.43 (0.97, 2.09)
1.03 (0.45, 2.36)
1.40 (0.97, 2.01)
1.05 (0.73, 1.50)
1.31 (1.05, 1.63)
3.58 (1.40, 9.19)
1.64 (0.86, 3.10)
Odds Ratio (95% CI)
1.18 (0.92, 1.51)
0.88 (0.67, 1.16)
0.05 1.00 20.80
Figure 2. Study-specific odds ratios and fixed- and random-effects meta-analysis odds ratios for paternal ever-smoking and risk of acute myeloid
leukemia in Childhood Leukemia International Consortium (CLIC) and non-CLIC studies between 1990 and 2014. Odds ratios for CLIC studies were
generated by using original data. TheP value for heterogeneity between groups is 0.026. The solid line represents the reference for “no association,”
and the dashed line represents the risk estimate from the fixed-effect meta-analysis. CI, confidence interval.
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Table 6. Risk of Acute Myeloid Leukemia AssociatedWith Number of Cigarettes Smoked per Day by the Mother and
Father, by Period of Exposure, Childhood Leukemia International Consortium, 1974–2012
Window of Exposure and
Smoking Status
No. of
Studies
Controls, no. Cases, no. ORa 95% CI
Mother
Prenatal 11
Nonsmokers 6,037 512 1.00 Referent
Moderate smokersb 2,074 130 0.82 0.66, 1.00
Heavy smokersc 4,321 404 0.74 0.50, 1.11
Per 5 cigarettes/dayd 12,432 1,046 0.99 0.98, 1.00
Preconception 6
Nonsmokers 5,569 461 1.00 Referent
Moderate smokersb 1,576 99 0.82 0.65, 1.04
Heavy smokersc 854 54 0.83 0.61, 1.13
Per 5 cigarettes/dayd 7,999 614 0.95 0.89, 1.01
Pregnancy 9
Nonsmokers 8,448 723 1.00 Referent
Moderate smokersb 1,812 139 0.96 0.79, 1.17
Heavy smokersc 383 23 0.68 0.44, 1.07
Per 5 cigarettes/dayd 10,643 885 0.96 0.89, 1.03
Postnatal 4
Nonsmokers 3,544 301 1.00 Referent
Moderate smokersb 570 41 0.87 0.61, 1.23
Heavy smokersc 206 10 0.54 0.28, 1.04
Per 5 cigarettes/dayd 4,320 352 0.92 0.82, 1.04
Father
Prenatal 7
Nonsmokers 5,296 375 1.00 Referent
Moderate smokersb 1,726 141 1.18 0.96, 1.45
Heavy smokersc 1,949 174 1.31 1.08, 1.60
Per 5 cigarettes/dayd 8,971 690 1.06 1.02, 1.10
Preconception 5
Nonsmokers 3,252 254 1.00 Referent
Moderate smokersb 1,113 85 1.04 0.79, 1.35
Heavy smokersc 1,217 117 1.37 1.07, 1.77
Per 5 cigarettes/dayd 5,582 456 1.06 1.02, 1.11
Pregnancy 3
Nonsmokers 2,283 149 1.00 Referent
Moderate smokersb 884 58 1.03 0.74, 1.44
Heavy smokersc 997 89 1.41 1.06, 1.89
Per 5 cigarettes/dayd 4,164 296 1.06 1.01, 1.12
Postnatal 3
Nonsmokers 2,546 139 1.00 Referent
Moderate smokersb 779 43 0.93 0.65, 1.33
Heavy smokersc 937 68 1.27 0.93, 1.73
Per 5 cigarettes/dayd 4,262 250 1.03 0.97, 1.10
Abbreviations: CI, confidence interval; OR, odds ratio.
a Odds ratios were adjusted for age, sex, ethnicity, highest parental education (using imputed values for mothers
when needed), and study center.
b Moderate smokers are defined as smoking 1–15 cigarettes per day.
c Heavy smokers are defined as smoking 16 or more cigarettes per day.
d Odds ratios were computed with the continuous variable provided, divided by 5.
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and Washington State (12 cases and 95 controls; OR = 6.30,
95% CI: 0.39, 101.1; data not shown). Analyses stratiﬁed by
age, birth weight, and highest parental education led to incon-
clusive ﬁndings (Table 3).
Paternal smoking during any period was associated with
increased risks of childhood AML with pooled odds ratios
ranging from 1.18 to 1.34 (Table 4). Similar results were ob-
served when analyses were restricted to households with non-
smoking mothers (∼25%) and for analyses of concurrent
paternal and maternal ever-smoking versus nonsmoking par-
ents (data not shown). Sensitivity analyses indicated that the
mean odds ratio for childhood AML associated with paternal
ever-smoking remained >1 for all 15 possible combinations
of studies (Web Figure 1). The magnitude of the association
with paternal ever-smoking was lower among non-Hispanic
whites, compared with other ethnicities (P for interaction = 0.08)
(Table 5). Despite heterogeneity among CLIC studies, the ﬁxed-
and random-effects meta odds ratios were similar to the
pooled odds ratios, ranging from 1.2 to 1.4 depending on
the time period (Figure 2 and Web Figures 6–8). For non-
CLIC studies, the study-speciﬁc odds ratios for paternal
smoking were below or close to 1 for all periods, resulting
in overall meta odds ratios of smaller magnitude, yet above
1 (Figure 2 and Web Figures 6–8).
Among non-Hispanic white controls, 36% and 17% of
smoking mothers smoked 16 cigarettes or more per day before
conception and during pregnancy, respectively, suggesting that
heavy smoking among smokers was not rare. However, fewer
Hispanic mothers reported smoking 16 cigarettes or more per
day before conception (7%) and during pregnancy (3%). Over-
all, the odds ratios did not increase with increasing amount of
maternal smoking (Table 6), except forHispanicmothers during
pregnancy (for an increase of 5 cigarettes per day, OR = 1.81,
95% CI: 1.11, 2.96). The highest level of paternal smoking
(≥16 cigarettes per day) in all time periods was associated
with the greatest risk ofAML (Table 6); however, dose-response
relationships were statistically signiﬁcant only for the prenatal
periods. The mean duration of paternal smoking in the prenatal
period was similar between cases and controls (16.2 and 17.2
years, respectively; P for t test = 0.21), and the odds ratio for
every year of smoking was 1.01 (95% CI: 0.98, 1.03). About
80% of fathers continued to smoke after the child’s birth, and
the mean duration of smoking did not vary between cases and
controls (P for t test = 0.60).
Although modestly increased odds ratios were observed for
some AML subtypes, only the association between paternal
ever-smoking and acute myelomonocytic leukemia (desig-
nated M4 in the French-American-British (FAB) classiﬁca-
tion) was statistically signiﬁcant (OR = 1.87, 95% CI: 1.08,
3.25) (Table 7). Maternal ever-smoking was also associated
with an increased risk of M4 (OR = 1.80, 95% CI: 1.09,
2.97), but this association weakened after adjustment for pater-
nal smoking (OR = 1.49, 95% CI: 0.87, 2.53). There were no
statistically signiﬁcant increased risks of AML with MLL fu-
sion in relation to paternal or maternal ever-smoking.
DISCUSSION
The current study, based on individual data from 12 case-
control studies in Europe, the Americas, andOceania, is the larg-
est to date to investigate the role of parental smoking in the eti-
ology of childhood AML. Our pooled analyses support the
association between paternal smoking and childhood AML;
however, the high correlation between pre- and postnatal paternal
smoking limited our ability to identify speciﬁc windows of ex-
posure. Overall, no associations were detected between mater-
nal smoking and childhood AML. Meta-analyses including
both CLIC and non-CLIC case-control studies (9–15, 35–
39) led to similar ﬁndings for maternal smoking, although
the magnitude of the associations was decreased for paternal
smoking.
There was a suggestion that the increased risk of AML as-
sociated with maternal smoking during pregnancy was ob-
served in Hispanic children. The ﬁndings for Hispanics
were based on studies in Costa Rica and Mexico, as well as
2 US studies in California and Washington states that ac-
counted for 42% and 11% of Hispanics, respectively (includ-
ing 83%–88% from Mexican origin on the basis of census
data from 2011 (40, 41) and self-report in the California
study). This is the ﬁrst study to examine the risk of tobacco
smoking and childhood AML in Hispanics, an ethnic group
that has experienced a rising incidence of childhood leukemia
(3), as well as rising prevalence of smoking among women
(42–44). Our ﬁndings may be due to population heterogeneity,
study-speciﬁc biases, or chance. Alternatively, differences by
ethnic groupmay be explained by variation in types of tobacco
used (black or blond) (45–49) and, consequently, differences
in concentrations of carcinogens, such as N-nitroso com-
pounds. Also, genes involved in transport and metabolism of
Table 7. Risk of Acute Myeloid Leukemia FAB Subtype and MLL
Rearrangement Status in Relation to Paternal Ever-Smoking,
Childhood Leukemia International Consortium, 1974–2012
FAB Subtype
Total
Cases, no.
Exposed
Cases, %
ORa 95% CI
M0 23 65 1.33 0.54, 3.24
M1 43 51 0.83 0.45, 1.55
M2 116 62 1.35 0.91, 2.01
M3 45 62 1.55 0.83, 2.91
M4 60 65 1.87 1.08, 3.25
M5 80 48 0.76 0.48, 1.21
M6 10 40 0.59 0.16, 2.20
M7 42 55 1.25 0.66, 2.36
MLL rearrangement
Negative 338 57 1.19 0.95, 1.50
Positive 41 51 1.08 0.57, 2.03
Abbreviations and designations: CI, confidence interval; FAB,
French-American-British (classification); M0, acute myeloblastic
leukemia, minimally differentiated; M1, acute myeloblastic leukemia,
without maturation; M2, acute myeloblastic leukemia, with
graulocytic maturation; M3, acute promyelocytic leukemia; M4, acute
myelomonocytic leukemia; M5, acute monoblastic/monocytic
leukemia; M6, acute erythroid leukemia; M7, acute megaloblastic
leukemia; MLL, mixed lineage leukemia gene; OR, odds ratio.
a Odds ratios were adjusted for age, sex, ethnicity, highest parental
education, and study center.
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tobacco-related chemicals have been found to differ in non-
Hispanics versus Hispanics (50, 51).
Similar to our ﬁndings, those of previous studies have sug-
gested a positive dose-response relationshipwith paternal smok-
ing, although based on unstable estimates. A study from
China reported a 2.3-fold (95% CI: 0.4, 14.8) increase in
risk of childhood AMLwith preconception paternal smoking
of 5 or more pack-years, whereas no associations were seen
for lesser amounts (35). In a US study of 88 infants with
AML (15), higher risk of childhood leukemia was observed
among fathers’ smoking more than 20 cigarettes per day (OR =
1.29, 95% CI: 0.44, 3.74). A study conducted in the United
Kingdom reported a positive dose-response relationship with
lifetime paternal smoking and childhood AML, using death as
a surrogate for leukemia diagnosis (n = 190 from 1971 to 1976)
(39), although a later study did not (n = 145 from 1977 to 1981)
(37). A larger case-control study conducted in the United States
failed to support an association with paternal ever-smoking or
during any time period, and no evidence of a dose-response re-
lationship was found (n = 517 from 1989 to 1993) (9). Duration
of smoking was not associated with an increased risk of child-
hoodAML in our study. Brondum et al. (9) reported a decreased
risk with increasing smoking duration (P for trend = 0.06),
whereas no other childhood AML studies have published data.
Few fathers changed their smoking habits over time, lim-
iting our ability to assess the independent contribution of pre-
versus. postnatal exposure to tobacco. Under the assumption
that maternal smoking before birth (for non-Hispanic chil-
dren) and after birth does not induce AML in the index
child, it is possible that preconception paternal smoking con-
tributes to AML risk, either solely, or in combination with
postnatal smoking. Such associations have also been reported
for risk of childhood acute lymphoblastic leukemia (18, 30,
52). These epidemiologic observations are supported by lab-
oratory studies showing that tobacco smoke is a germ-cell
mutagen in rodents, and likely in humans (53), and can in-
duce germ cell epigenetic changes (54). A child’s exposure
to secondhand smoking, however, may also contribute to
the development of AML (18). The CLIC study from Italy
reported an increased risk of AML associated with precon-
ception paternal smoking only among mothers less than 30
years of age at delivery (25), but we did not reproduce this
ﬁnding in our pooled analyses (data not shown).
We observed increased risks of M4 in children of smoking
fathers and, possibly, smoking mothers. Nonstatistically sig-
niﬁcant odds ratios were also observed between paternal
smoking and acute myeloblastic leukemia, minimally differ-
entiated (FAB subtype M0), acute myeloblastic leukemia,
with granulocytic maturation (FAB subtype M2), and acute
promyelocytic leukemia (FAB subtypeM3). However, the in-
terpretation of our subtype analyses is limited by small sample
sizes. Another case-control study also reported associations of
larger magnitude between childhoodM4 leukemia and mater-
nal ever-smoking (n = 37 cases) (13). Studies conducted in
adults have reported a higher frequency of M2, M4, acute
monoblastic/monocytic leukemia (FAB subtype M5), and
acute erythroid leukemia (FAB subtype M6) among smokers,
whereas acute myeloblastic leukemia without maturation
(FAB subtype M1) and M3 were more frequent in nonsmokers
(16, 39, 55). Treatment-related M2 frequently occurs in patients
treated with alkylating agents and radiation, and FAB subtypes
M3,M4, andM5occur after exposure to topoisomerase II inhib-
itors (56, 57), suggesting that some metabolic pathways may be
shared between tobacco- and treatment-induced AML. We ob-
served no difference in risk for children classiﬁed asMLL posi-
tive andMLL negative. TheMLL fusion is more frequent among
infants with leukemia (58), and a study of 88 infant AMLs re-
ported no association with parental smoking (15). In contrast,
a recent case-case study found that maternal smoking during
pregnancy resulted in a 3-fold increased risk of AML with
MLL rearrangement (n = 57) compared withMLL negative (n
= 59) (59). The occurrence of AMLwithMLL fusion proteins
may be further modulated by inherited genetic susceptibility
factors (60, 61).
Our analyses have some limitations. Selection bias may
occur in case-control studies if parents’ participation is de-
pendent on the exposure of interest, here smoking habit,
and is correlated with sociodemographic factors or race/eth-
nicity. The distribution of educational levels varied among
participating CLIC studies (i.e., lower education in cases
vs. controls in 4 studies, lower education in controls vs.
cases in 1 study, and no difference between cases and con-
trols in 7 studies). As a result, it is difﬁcult to assess the mag-
nitude of selection bias and the inﬂuence on the overall
pooled risk estimates. However, the observation of both pos-
itive and negative ﬁndings in our analyses argues against
strong selection bias. There is a concern, especially among
pregnant women, that recall of smoking history may be inac-
curate (62). Studies have reported a lack of concordance be-
tween self-reported smoking during pregnancy and cotinine
blood level in mothers and newborns (63, 64). Also, com-
pared with nonpregnant women, pregnant women are more
likely to underreport smoking (63) or exhibit unstable smok-
ing habits (65). In most studies, mothers provided infor-
mation for paternal smoking, and it has been shown that
spouses of cases and controls usually report paternal smoking
accurately (18, 66, 67). We compared smoking prevalence in
CLIC studies with population-based data, and for CLIC stud-
ies conducted in the United Kingdom, Greece, Italy, Mexico,
and Brazil, the prevalence of smoking for mothers and fathers
(among controls) was higher by approximately 6%–8%,
compared with population-based data (68–72) that were
available for the corresponding study periods and the corre-
sponding age groups; the population-based data for Ger-
many, France, Costa Rica, and California were available
after the corresponding CLIC study period and suggested
the same trend (73–76). In contrast, the prevalence of smok-
ing among controls in the birth registry-based study con-
ducted in Washington State was lower than the prevalence
reported in the general population (77), and it is possible
that mothers underreported smoking at the interviews con-
ducted by hospital staff soon after the child’s birth. Overall,
this may indicate that subjects participating in the CLIC case-
control studies overreported smoking habits or represent a se-
lected group not representative of the general population.
However, our data indicated that maternal smoking was cor-
related with low birth weight in both cases and controls (data
not shown), consistent with the well-established observation
that maternal smoking induces intrauterine growth retarda-
tion (78). This observation indirectly suggests that recall
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bias may not fully explain the negative ﬁndings for maternal
smoking (among non-Hispanics). Alternatively, maternal
smoking during pregnancy is associated with stillbirth and
miscarriage (79), which could represent a competing out-
come preventing our evaluation of childhood leukemia risk.
Although alcohol consumption during pregnancy has been
associated with a 1.5-fold increased risk of childhood AML
(17, 80), there was no evidence of confounding (or effect
modiﬁcation) with alcohol use in our analyses. No other
factors affected the observed associations, but residual con-
founding from unmeasured factors is possible. In previous
CLIC pooled analyses on prenatal folate and vitamin sup-
plementation, we observed that adjustment for study site
accounted for confounding by measured and unmeasured
study characteristics, even when the heterogeneity between
studies is large (81). Meta-analyses indicated some heteroge-
neity for paternal smoking, and to a lesser extent for maternal
smoking. Nevertheless, exclusion of studies resulted in rela-
tively stable estimates, indicating that results were not largely
driven by speciﬁc studies. Finally, it is possible that multiple
comparisons may have led to false positive ﬁndings. Despite
limitations, the strengths of the CLIC pooled analyses are
the inclusion of published and unpublished original data,
large sample size for a rare disease like childhood AML, in-
clusion of Hispanic children, and the ability to conduct sub-
group and dose-response analyses, as well as adjustment for
confounders.
In conclusion, we observed an association between pater-
nal smoking and childhood AML. Findings for maternal
smoking remained mostly null, except possibly for Hispanic
children exposed in utero. Until associations with maternal
smoking are further elucidated, and given the many health
risks associated with smoking, it is important to educate fam-
ilies and health professionals on preventing fathers, mothers,
and children from being exposed to tobacco smoke before
and after the child’s birth.
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